An R307H Substitution in GATA1 That Prevents Ser310 Phosphorylation Causes Severe Fetal Anemia

Overview

Journal Blood Adv

Specialty Hematology

Date 2022 May 17

PMID 35580337

Authors

Benjamin Hetzer

Andreas Meryk

Gabriele Kropshofer

Caroline Bargehr

Raul Jimenez-Heredia

Kaan Boztug

Beatrix E Muhlegger

Michael Dworzak

Thomas Gruber

Roman Crazzolara

Affiliations

Soon will be listed here.

Citing Articles

GATA1 in Normal and Pathologic Megakaryopoiesis and Platelet Development.

Takasaki K, Chou S Adv Exp Med Biol. 2024; 1459:261-287.

PMID: 39017848 DOI: 10.1007/978-3-031-62731-6_12.

HEXIM1 is an essential transcription regulator during human erythropoiesis.

Lv X, Murphy K, Murphy Z, Getman M, Rahman N, Nakamura Y Blood. 2023; 142(25):2198-2215.

PMID: 37738561 PMC: 10733840. DOI: 10.1182/blood.2022019495.

A Novel GATA1 Variant in the C-Terminal Zinc Finger Compared with the Platelet Phenotype of Patients with A Likely Pathogenic Variant in the N-Terminal Zinc Finger.

Bastida J, Malvestiti S, Boeckelmann D, Palma-Barqueros V, Wolter M, Lozano M Cells. 2022; 11(20).

PMID: 36291092 PMC: 9600848. DOI: 10.3390/cells11203223.

Novel Variant Causing a Bleeding Phenotype Associated with Combined Platelet α-/δ-Storage Pool Deficiency and Mild Dyserythropoiesis Modified by a Variant.

Jurk K, Adenaeuer A, Sollfrank S, Gross K, Hauser F, Czwalinna A Cells. 2022; 11(19).

PMID: 36231035 PMC: 9564339. DOI: 10.3390/cells11193071.

References

Ciovacco W, Raskind W, Kacena M . Human phenotypes associated with GATA-1 mutations. Gene. 2008; 427(1-2):1-6. PMC: 2601579. DOI: 10.1016/j.gene.2008.09.018. View

Miccio A, Blobel G . Role of the GATA-1/FOG-1/NuRD pathway in the expression of human beta-like globin genes. Mol Cell Biol. 2010; 30(14):3460-70. PMC: 2897567. DOI: 10.1128/MCB.00001-10. View

Nichols K, Crispino J, Poncz M, White J, Orkin S, Maris J . Familial dyserythropoietic anaemia and thrombocytopenia due to an inherited mutation in GATA1. Nat Genet. 2000; 24(3):266-70. PMC: 10576470. DOI: 10.1038/73480. View

Yoshida K, Toki T, Okuno Y, Kanezaki R, Shiraishi Y, Sato-Otsubo A . The landscape of somatic mutations in Down syndrome-related myeloid disorders. Nat Genet. 2013; 45(11):1293-9. DOI: 10.1038/ng.2759. View

Rooke H, Orkin S . Phosphorylation of Gata1 at serine residues 72, 142, and 310 is not essential for hematopoiesis in vivo. Blood. 2006; 107(9):3527-30. PMC: 1895769. DOI: 10.1182/blood-2005-10-4309. View

Bottardi S, Ross J, Bourgoin V, Fotouhi-Ardakani N, Affar E, Trudel M . Ikaros and GATA-1 combinatorial effect is required for silencing of human gamma-globin genes. Mol Cell Biol. 2008; 29(6):1526-37. PMC: 2648246. DOI: 10.1128/MCB.01523-08. View

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J . Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015; 17(5):405-24. PMC: 4544753. DOI: 10.1038/gim.2015.30. View

Phillips J, Steensma D, Pulsipher M, Spangrude G, Kushner J . Congenital erythropoietic porphyria due to a mutation in GATA1: the first trans-acting mutation causative for a human porphyria. Blood. 2006; 109(6):2618-21. PMC: 1852202. DOI: 10.1182/blood-2006-06-022848. View

Suzuki M, Yamamoto M, Engel J . Fetal globin gene repressors as drug targets for molecular therapies to treat the β-globinopathies. Mol Cell Biol. 2014; 34(19):3560-9. PMC: 4187729. DOI: 10.1128/MCB.00714-14. View

10.

Freson K, Devriendt K, Matthijs G, Van Hoof A, De Vos R, Thys C . Platelet characteristics in patients with X-linked macrothrombocytopenia because of a novel GATA1 mutation. Blood. 2001; 98(1):85-92. DOI: 10.1182/blood.v98.1.85. View

11.

Wechsler J, Greene M, McDevitt M, Anastasi J, Karp J, Le Beau M . Acquired mutations in GATA1 in the megakaryoblastic leukemia of Down syndrome. Nat Genet. 2002; 32(1):148-52. DOI: 10.1038/ng955. View

12.

Zhao W, Kitidis C, Fleming M, Lodish H, Ghaffari S . Erythropoietin stimulates phosphorylation and activation of GATA-1 via the PI3-kinase/AKT signaling pathway. Blood. 2005; 107(3):907-15. PMC: 1895894. DOI: 10.1182/blood-2005-06-2516. View

13.

Crispino J, Horwitz M . GATA factor mutations in hematologic disease. Blood. 2017; 129(15):2103-2110. PMC: 5391620. DOI: 10.1182/blood-2016-09-687889. View

14.

Kadri Z, Lefevre C, Goupille O, Penglong T, Granger-Locatelli M, Fucharoen S . Erythropoietin and IGF-1 signaling synchronize cell proliferation and maturation during erythropoiesis. Genes Dev. 2015; 29(24):2603-16. PMC: 4699388. DOI: 10.1101/gad.267633.115. View

15.

Karczewski K, Francioli L, Tiao G, Cummings B, Alfoldi J, Wang Q . The mutational constraint spectrum quantified from variation in 141,456 humans. Nature. 2020; 581(7809):434-443. PMC: 7334197. DOI: 10.1038/s41586-020-2308-7. View

16.

Martin D, Tsai S, Orkin S . Increased gamma-globin expression in a nondeletion HPFH mediated by an erythroid-specific DNA-binding factor. Nature. 1989; 338(6214):435-8. DOI: 10.1038/338435a0. View

17.

Campbell A, Wilkinson-White L, Mackay J, Matthews J, Blobel G . Analysis of disease-causing GATA1 mutations in murine gene complementation systems. Blood. 2013; 121(26):5218-27. PMC: 3695365. DOI: 10.1182/blood-2013-03-488080. View

18.

Hollanda L, Lima C, Cunha A, Albuquerque D, Vassallo J, Ozelo M . An inherited mutation leading to production of only the short isoform of GATA-1 is associated with impaired erythropoiesis. Nat Genet. 2006; 38(7):807-12. DOI: 10.1038/ng1825. View

19.

Balduini C, Pecci A, Loffredo G, Izzo P, Noris P, Grosso M . Effects of the R216Q mutation of GATA-1 on erythropoiesis and megakaryocytopoiesis. Thromb Haemost. 2003; 91(1):129-40. DOI: 10.1160/TH03-05-0290. View

20.

Mehaffey M, Newton A, Gandhi M, Crossley M, Drachman J . X-linked thrombocytopenia caused by a novel mutation of GATA-1. Blood. 2001; 98(9):2681-8. DOI: 10.1182/blood.v98.9.2681. View